2nd Day- 3rd Talk: “Angiogenesis Protein Therapy with Human Fibroblast Growth Factor” by Lynne Wagoner, MD

Dr. Lynne Wagoner was the Principal Investigator for CVBT’s Phase I Sever CHD clinical trial at the University of Cincinnati Medical Center. Dr. Wagoner currently practices with Greater Cincinnati Cardiovascular Consultants (GCCC) and is the Principal Investigator in twelve ongoing funded studies in heart failure.

Coming...